177 related articles for article (PubMed ID: 32578050)
1. KIF15 contributes to cell proliferation and migration in breast cancer.
Gao X; Zhu L; Lu X; Wang Y; Li R; Jiang G
Hum Cell; 2020 Oct; 33(4):1218-1228. PubMed ID: 32578050
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.
Sheng J; Xue X; Jiang K
Curr Mol Med; 2019; 19(2):147-155. PubMed ID: 30854965
[TBL] [Abstract][Full Text] [Related]
3. Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma.
Qiao Y; Chen J; Ma C; Liu Y; Li P; Wang Y; Hou L; Liu Z
Cell Physiol Biochem; 2018; 51(1):1-10. PubMed ID: 30439711
[TBL] [Abstract][Full Text] [Related]
4. PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy.
Wang X; Li Y; Fan Y; Yu X; Mao X; Jin F
J Cell Physiol; 2018 Nov; 233(11):8930-8939. PubMed ID: 29856478
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA LINC01287 promotes breast cancer cells proliferation and metastasis by activating Wnt/ß-catenin signaling.
Song C; Sun P; He Q; Liu LL; Cui J; Sun LM
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4234-4242. PubMed ID: 31173295
[TBL] [Abstract][Full Text] [Related]
6. KIF15 promotes the evolution of gastric cancer cells through inhibition of reactive oxygen species-mediated apoptosis.
Tao J; Sun G; Li Q; Zhi X; Li Z; He Z; Chen H; Zhou A; Ye J; Xu G; Guan W; Zhang W
J Cell Physiol; 2020 Dec; 235(12):9388-9398. PubMed ID: 32342525
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Kinesin Family 15 Inhibits Osteosarcoma through Suppressing Cell Proliferation and Promoting Cell Apoptosis.
Wu Z; Zhang H; Sun Z; Wang C; Chen Y; Luo P; Yan W
Chemotherapy; 2019; 64(4):187-196. PubMed ID: 32074608
[TBL] [Abstract][Full Text] [Related]
8. KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway.
Wang J; Guo X; Xie C; Jiang J
Br J Cancer; 2017 Jul; 117(2):245-255. PubMed ID: 28595260
[TBL] [Abstract][Full Text] [Related]
9. ZNF367-induced transcriptional activation of KIF15 accelerates the progression of breast cancer.
Zeng H; Li T; Zhai D; Bi J; Kuang X; Lu S; Shan Z; Lin Y
Int J Biol Sci; 2020; 16(12):2084-2093. PubMed ID: 32549756
[TBL] [Abstract][Full Text] [Related]
10. KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer.
Wang J; Ma S; Ma R; Qu X; Liu W; Lv C; Zhao S; Gong Y
BMC Cancer; 2014 Jun; 14():461. PubMed ID: 24950762
[TBL] [Abstract][Full Text] [Related]
11. miR-21: A gene of dual regulation in breast cancer.
Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
[TBL] [Abstract][Full Text] [Related]
12. Noxin promotes proliferation of breast cancer cells via P38-ATF2 signaling pathway.
Zhang X; Zhang Y; Fan C; Wang L; Liu Y; Li A; Jiang G; Zhou H; Cai L; Miao Y
Tumour Biol; 2017 Jun; 39(6):1010428317705515. PubMed ID: 28618963
[TBL] [Abstract][Full Text] [Related]
13. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
[TBL] [Abstract][Full Text] [Related]
14. KIF15 upregulation promotes leiomyosarcoma cell growth via promoting USP15-mediated DEK deubiquitylation.
Ge W; Chen Y; Guo Y; Zhao D; Mu L; Zhang K; Zhuo W
Biochem Biophys Res Commun; 2021 Sep; 570():117-124. PubMed ID: 34280614
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
16. Suppression of motor protein KIF3C expression inhibits tumor growth and metastasis in breast cancer by inhibiting TGF-β signaling.
Wang C; Wang C; Wei Z; Li Y; Wang W; Li X; Zhao J; Zhou X; Qu X; Xiang F
Cancer Lett; 2015 Nov; 368(1):105-114. PubMed ID: 26272184
[TBL] [Abstract][Full Text] [Related]
17. VIRMA Facilitates Triple-Negative Breast Cancer Progression via Increasing m6A-Dependent KIF15 Expression.
Chen C; Wang Y; Li Y; Zhang C
Discov Med; 2023 Oct; 35(178):787-795. PubMed ID: 37811616
[TBL] [Abstract][Full Text] [Related]
18. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
20. miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer.
Zhou Y; Wang M; Tong Y; Liu X; Zhang L; Dong D; Shao J; Zhou Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819875168. PubMed ID: 31506061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
